Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020755

Expand all

CAVERJECT (ALPROSTADIL)
0.005MG/ML
Marketing Status: Discontinued

Active Ingredient: ALPROSTADIL
Proprietary Name: CAVERJECT
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.005MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020755
Product Number: 001
Approval Date: Oct 31, 1997
Applicant Holder Full Name: PFIZER INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CAVERJECT (ALPROSTADIL)
0.01MG/ML
Marketing Status: Discontinued

Active Ingredient: ALPROSTADIL
Proprietary Name: CAVERJECT
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.01MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020755
Product Number: 002
Approval Date: Oct 1, 1997
Applicant Holder Full Name: PFIZER INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CAVERJECT (ALPROSTADIL)
0.02MG/ML
Marketing Status: Discontinued

Active Ingredient: ALPROSTADIL
Proprietary Name: CAVERJECT
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.02MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020755
Product Number: 003
Approval Date: Oct 1, 1997
Applicant Holder Full Name: PFIZER INC
Marketing Status:  Discontinued
Patent and Exclusivity Information